Evidence map›Paper›PMID 23973174›Full record

ArticleBiomaterials2013

Paracrine exchanges of molecular signals between alginate-encapsulated pericytes and freely suspended endothelial cells within a 3D protein gel.

Jillian W Andrejecsk, Jiajia Cui, William G Chang, Julie Devalliere, Jordan S Pober, W Mark Saltzman

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Fabrication of New Hybrid Scaffolds forFrontiers in cardiovascular medicine · 2020
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Pericyte-targeting drug delivery and tissue engineering.International journal of nanomedicine · 2016
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jillian W AndrejecskDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.
Jiajia Cui
William G Chang
Julie Devalliere
Jordan S Pober
W Mark Saltzman
Yale University · US

Funding

PATHOPHYSIOLOGY OF ACUTE AND CHRONIC RENAL DISEASET32DK007276 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S., CANTLEY, LLOYD G · 1986 to 2022
$9.3M
Optimizing Therapeutic Revascularization by Endothelial Cell TransplantationR01HL085416 · NHLBI · YALE UNIVERSITY · PI POBER, JORDAN S, SALTZMAN, W. MARK · 2006 to 2019
$5.9M
Yale University Clinical and Translational Science Award ProgramKL2RR024138 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$4.8M
Yale University Clinical and Translational Science Award ProgramTL1RR024137 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$3.2M
NCRR NIH HHS KL2 RR024138NCRR NIH HHS TL1 RR024137NHLBI NIH HHS R01 HL085416NHLBI NIH HHS R01-HL085416NIDDK NIH HHS T32 DK007276
6 · The paper itself

Abstract

Paracrine signals, essential for the proper survival and functioning of tissues, may be mimicked by delivery of therapeutic proteins within engineered tissue constructs. Conventional delivery methods are of limited duration and are unresponsive to the local environment. We developed a system for sustained and regulated delivery of paracrine signals by encapsulating living cells of one type in alginate beads and co-suspending these cell-loaded particles along with unencapsulated cells of a second type within a 3D protein gel. This system was applied to vascular tissue engineering by placing human placental microvascular pericytes (PCs) in the particulate alginate phase and human umbilical vein endothelial cells (HUVECs) in the protein gel phase. Particle characteristics were optimized to keep the encapsulated PCs viable for at least two weeks. Encapsulated PCs were bioactive in vitro, secreting hepatocyte growth factor, an angiogenic protein, and responding to externally applied HUVEC-derived signals. Encapsulated PCs influenced HUVEC behavior in the surrounding gel by enhancing the formation of vessel-like structures when compared to empty alginate bead controls. In vivo, encapsulated PCs modulated the process of vascular self-assembly by HUVECs in 3D gels following implantation into immunodeficient mice. We conclude that alginate encapsulated cells can provide functional paracrine signals within engineered tissues.

Indexed as

AlginatesAnimalsCell LineCells, ImmobilizedEndothelial CellsGelsGlucuronic AcidHexuronic AcidsHumansHuman Umbilical Vein Endothelial CellsMaleMiceMice, SCIDMicrovesselsParacrine CommunicationParticle SizeAlginatesGelsGlucuronic AcidHexuronic AcidsAlginateCell encapsulationCo-culturePericyteProtein deliveryVascular tissue engineering

Identifiers

PMID23973174
PMCPMC3839675
OpenAlexW2008160222

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.